ArticleESMO real world data and digital oncology2026
Real-world patient characteristics and utilization patterns in patients with cholangiocarcinoma who received pemigatinib in the United States of America.
S Verma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.